Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Heart Failure Reports
Published in: Current Heart Failure Reports 5/2016

01-10-2016 | Epidemiology of Heart Failure (J Ho, Section Editor)

Burden of Heart Failure in Adults with Congenital Heart Disease

Authors: Laith I. Alshawabkeh, Alexander R. Opotowsky

Published in: Current Heart Failure Reports | Issue 5/2016

Login to get access

Abstract

Patients born with congenital heart disease (CHD) have benefited from remarkable advances in surgical and catheter-based interventions. As a result, the majority of children born with even the most complex forms of CHD live into adulthood. The specialized field of adult CHD (ACHD) was born out of the necessity to care for this new population of survivors of childhood CHD and their distinctive features. In this review, relevant aspects of ACHD that lead to, and are affected by, heart failure will be examined along with the increasing prevalence of HF in the burgeoning population of ACHD. We also highlight the challenges in defining HF in this particular group of patients.
Literature
1.
Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56(14):1149–57.PubMedCrossRef
2.
Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749–56.PubMedCrossRef
3.
Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22–29 years). Eur Heart J. 2004;25(14):1264–70.PubMedCrossRef
4.
Williams RG, Pearson GD, Barst RJ, et al. Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. J Am Coll Cardiol. 2006;47(4):701–7.PubMedCrossRef
5.
Mylotte D, Pilote L, Ionescu-Ittu R, et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation. 2014;129(18):1804–12.PubMedCrossRef
6.
Bolger AP, Coats AJ, Gatzoulis MA. Congenital heart disease: the original heart failure syndrome. Eur Heart J. 2003;24(10):970–6.PubMedCrossRef
7.
McLarry J, Broberg C, Opotowsky AR, et al. Defining heart failure in adult congenital heart disease. Prog Pediatr Cardiol. 2014;38(1):3–7.
8.
Stout KK, Broberg CS, Book WM, et al. Chronic heart failure in congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2016;133(8):770–801.PubMed
9.
Norozi K, Wessel A, Alpers V, et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol. 2006;97(8):1238–43.PubMedCrossRef
10.
Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112(6):828–35.PubMedCrossRef
11.
12.
McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285(26):1441–6.PubMedCrossRef
13.
Piran S, Veldtman G, Siu S, Webb GD, Liu PP. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation. 2002;105(10):1189–94.PubMedCrossRef
14.
Gurvitz M, Valente AM, Broberg C, et al. Prevalence and predictors of gaps in care among adult congenital heart disease patients: HEART-ACHD (The Health, Education, and Access Research Trial). J Am Coll Cardiol. 2013;61(21):2180–4.PubMedPubMedCentralCrossRef
15.
Yeung E, Kay J, Roosevelt GE, Brandon M, Yetman AT. Lapse of care as a predictor for morbidity in adults with congenital heart disease. Int J Cardiol. 2008;125(1):62–5.PubMedCrossRef
16.
Aboulhosn JA, Lluri G, Gurvitz MZ, et al. Left and right ventricular diastolic function in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Can J Cardiol. 2013;29(7):866–72.PubMedCrossRef
17.
Tutarel O, Kempny A, Alonso-Gonzalez R, et al. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J. 2014;35(11):725–32.PubMedCrossRef
18.
Gelatt M, Hamilton RM, McCrindle BW, et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol. 1997;29(1):194–201.PubMedCrossRef
19.
Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol. 2002;40(9):1675–80.PubMedCrossRef
20.
Puley G, Siu S, Connelly M, et al. Arrhythmia and survival in patients >18 years of age after the mustard procedure for complete transposition of the great arteries. Am J Cardiol. 1999;83(7):1080–4.PubMedCrossRef
21.
Broberg CS, Aboulhosn J, Mongeon FP, et al. Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of fallot. Am J Cardiol. 2011;107(8):1215–20.PubMedCrossRef
22.
Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol. 2004;43(6):1068–74.PubMedCrossRef
23.
Valente AM, Gauvreau K, Assenza GE, et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014;100(3):247–53.PubMedCrossRef
24.
Miyamoto K, Takeuchi D, Inai K, Shinohara T, Nakanishi T. Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles. Heart Vessels. 2016:1–14.
25.
Eindhoven JA, Roos-Hesselink JW, van den Bosch AE, et al. High-sensitive troponin-T in adult congenital heart disease. Int J Cardiol. 2015;184:405–11.PubMedCrossRef
26.
Lai CT, Wong SJ, Ip JJ, et al. Plasma levels of high sensitivity cardiac troponin T in adults with repaired tetralogy of Fallot. Sci Rep. 2015;5:14050.PubMedPubMedCentralCrossRef
27.
Uner A, Dogan M, Ay M, Acar C. The evaluation of serum N-terminal prohormone brain-type natriuretic peptide, troponin-I, and high-sensitivity C-reactive protein levels in children with congenital heart disease. Hum Exp Toxicol. 2014;33(11):1158–66.PubMedCrossRef
28.
Opotowsky AR, Baraona FR, Owumi J, et al. Galectin-3 is elevated and associated with adverse outcomes in patients with single ventricle Fontan circulation. J Am Heart Assoc. 2016; 5:e002706. doi: 10.1161/JAHA.115.002706.
29.
Verheugt CL, Uiterwaal CS, van der Velde ET, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31(10):1220–9.PubMedCrossRef
30.
Engelings CC, Helm PC, Abdul-Khaliq H, et al. Cause of death in adults with congenital heart disease—an analysis of the German National Register for Congenital Heart Defects. Int J Cardiol. 2016;211:31–6.PubMedCrossRef
31.
Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009;54(5):460–7.PubMedCrossRef
32.
O’Leary JM, Siddiqi OK, de Ferranti S, Landzberg MJ, Opotowsky AR. The changing demographics of congenital heart disease hospitalizations in the United States, 1998 through 2010. JAMA. 2013;309(10):984–6.PubMedCrossRef
33.
Agarwal S, Sud K, Menon V. Nationwide hospitalization trends in adult congenital heart disease across 2003–2012. J Am Heart Assoc. 2016;5(1):e002330.PubMedPubMedCentral
34.
Islam S, Yasui Y, Kaul P, Marelli AJ, Mackie AS. Congenital heart disease hospitalizations in Canada: a 10-year experience. Can J Cardiol. 2016;32(2):197–203.PubMedCrossRef
35.
Rodriguez 3rd FH, Moodie DS, Parekh DR, et al. Outcomes of heart failure-related hospitalization in adults with congenital heart disease in the United States. Congenit Heart Dis. 2013;8(6):513–9.PubMedCrossRef
36.
Zomer AC, Vaartjes I, van der Velde ET, et al. Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int J Cardiol. 2013;168(3):2487–93.PubMedCrossRef
37.
Davies RR, Russo MJ, Yang J, Quaegebeur JM, Mosca RS, Chen JM. Listing and transplanting adults with congenital heart disease. Circulation. 2011;123(7):759–67.PubMedCrossRef
38.
Gelow JM, Song HK, Weiss JB, Mudd JO, Broberg CS. Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices. J Heart Lung Transplant. 2013;32(11):1059–64.PubMedPubMedCentralCrossRef
39.
Alshawabkeh L, Hu N, Carter KD, Light-McGroary K, Cavanaugh JE, Bartlett HL. Abstract 15875: waitlist outcomes for adults with congenital heart disease listed for heart transplantation in the United States. Circulation. 2015;132 Suppl 3:A15875.
40.
Cohen S, Houyel L, Guillemain R, et al. Temporal trends and changing profile of adults with congenital heart disease undergoing heart transplantation. Eur Heart J. 2016;37(9):783–9.PubMedCrossRef
41.
Krishnamurthy Y, Cooper LB, Lu D, et al. Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States. J Heart Lung Transplant. 2016;35(5):619–24.PubMedCrossRef
42.
Law YM, Ettedgui J, Beerman L, Maisel A, Tofovic S. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Am J Cardiol. 2006;98(4):520–4.PubMedCrossRef
43.
Khairy P, Fernandes SM, Mayer Jr JE, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117(1):85–92.PubMedCrossRef
Metadata
Title
Burden of Heart Failure in Adults with Congenital Heart Disease
Authors
Laith I. Alshawabkeh
Alexander R. Opotowsky
Publication date
01-10-2016
Publisher
Springer US
Published in
Current Heart Failure Reports / Issue 5/2016
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-016-0301-0

Other articles of this Issue 5/2016

Current Heart Failure Reports 5/2016 Go to the issue

Pharmacologic Therapy (W H W Tang, Section Editor)

Contemporary Controversies in Digoxin Use in Systolic Heart Failure

Comorbidities of Heart Failure (C Angermann, Section Editor)

Sleep-Disordered Breathing—Do We Have to Change Gears in Heart Failure?

Management of Heart Failure (T Meyer, Section Editor)

Newer Therapies for Amyloid Cardiomyopathy

Biomarkers of Heart Failure (W H W Tang, Section Editor)

Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure

Prevention of Heart Failure (MSJ Sutton, Section Editor)

Right Ventricular Versus Biventricular Pacing for Heart Failure and Atrioventricular Block

Prevention of Heart Failure (MSJ Sutton, Section Editor)

Cardiometabolic Syndrome and Increased Risk of Heart Failure
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits